rs7171137
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_013272.4(SLCO3A1):c.647-75484C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.423 in 152,046 control chromosomes in the GnomAD database, including 14,294 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.42   (  14294   hom.,  cov: 33) 
Consequence
 SLCO3A1
NM_013272.4 intron
NM_013272.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -2.11  
Publications
4 publications found 
Genes affected
 SLCO3A1  (HGNC:10952):  (solute carrier organic anion transporter family member 3A1) Predicted to enable sodium-independent organic anion transmembrane transporter activity. Involved in positive regulation of NF-kappaB transcription factor activity; positive regulation of protein phosphorylation; and prostaglandin transport. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.552  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| SLCO3A1 | NM_013272.4 | c.647-75484C>A | intron_variant | Intron 2 of 9 | ENST00000318445.11 | NP_037404.2 | ||
| SLCO3A1 | NM_001145044.1 | c.647-75484C>A | intron_variant | Intron 2 of 10 | NP_001138516.1 | |||
| SLCO3A1 | NR_135775.2 | n.574-75484C>A | intron_variant | Intron 2 of 10 | 
Ensembl
Frequencies
GnomAD3 genomes  0.423  AC: 64292AN: 151928Hom.:  14268  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
64292
AN: 
151928
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.423  AC: 64377AN: 152046Hom.:  14294  Cov.: 33 AF XY:  0.432  AC XY: 32078AN XY: 74306 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
64377
AN: 
152046
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
32078
AN XY: 
74306
show subpopulations 
African (AFR) 
 AF: 
AC: 
21205
AN: 
41484
American (AMR) 
 AF: 
AC: 
7381
AN: 
15276
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1147
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
2940
AN: 
5166
South Asian (SAS) 
 AF: 
AC: 
2743
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
4535
AN: 
10556
Middle Eastern (MID) 
 AF: 
AC: 
122
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
23173
AN: 
67962
Other (OTH) 
 AF: 
AC: 
861
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1863 
 3726 
 5588 
 7451 
 9314 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 594 
 1188 
 1782 
 2376 
 2970 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2031
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.